X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
a549 cells (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic combined chemotherapy protocols - pharmacology (1) 1
apoptosis (1) 1
apoptosis - drug effects (1) 1
candidate selection (1) 1
carbazoles - pharmacology (1) 1
carcinoma, non-small-cell lung - drug therapy (1) 1
carcinoma, non-small-cell lung - metabolism (1) 1
cell biology (1) 1
cell line, tumor (1) 1
cell membrane - drug effects (1) 1
cep 8983 (1) 1
cisplatin - pharmacology (1) 1
conjugate sirna (1) 1
cytochromes c - secretion (1) 1
death (1) 1
dna (1) 1
dna damage - drug effects (1) 1
dna damage response (1) 1
drug synergism (1) 1
enzyme inhibitors - pharmacology (1) 1
extra views (1) 1
female genital diseases and pregnancy complications (1) 1
humans (1) 1
index medicus (1) 1
inorganic chemicals (1) 1
lung neoplasms - drug therapy (1) 1
lung neoplasms - metabolism (1) 1
mitochondrial membranes - drug effects (1) 1
mitochondrial-membrane permeabilization (1) 1
molecular-mechanisms (1) 1
neoplasms (1) 1
p53 (1) 1
phenanthrenes - pharmacology (1) 1
phthalimides - pharmacology (1) 1
pj34 hydrochloride (1) 1
poly polymerase (1) 1
poly polymerase inhibitors (1) 1
poly polymerase-1 (1) 1
poly polymerases - genetics (1) 1
resistance (1) 1
rna interference (1) 1
rna, small interfering (1) 1
rnai molecular mechanism (1) 1
safety lead optimization (1) 1
sirna design (1) 1
small interfering rna (1) 1
small-interfering rna (1) 1
small-interfering rnad (1) 1
target assessment (1) 1
tumors (1) 1
vitamin-b6 metabolism (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cell Cycle, ISSN 1538-4101, 03/2013, Volume 12, Issue 6, pp. 877 - 883
Journal Article
04/2016, ISBN 9781119053330, 13
This chapter broadly describes the lead optimization activities relevant to the development of novel conjugate siRNA therapeutics for hepatic targets via... 
candidate selection | siRNA design | target assessment | conjugate siRNA | small interfering RNA | safety lead optimization | RNAi molecular mechanism | Candidate selection | Conjugate siRNA | Small interfering RNA | SiRNA design | Target assessment | Safety lead optimization
Book Chapter
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.